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Definition  
Glomerulonephritis (glomerular nephritis , GN) 
denotes group of primary and secondary acute and 
chronic kidney diseases (usually affecting both 
kidneys) mostly characterised by immune mediated 
inflammation in the glomerular capillaries and the 
glomerular basement membrane (GBM), that may 
present with isolated hematuria and/or proteinuria, 
or as a nephrotic syndrome, a nephritic syndrome, a 
hypertensive syndrome and their combinations 
associated with progressive kidney failure, high 
cholesterol and anemia.   
http://bestpractice.bmj.com/best-practice/monograph/207/basics.html 
USMLE TEST 
Multiple patients present to your office with hematuria 
following an outbreak of Group A Streptococcus. Biopsy 
reveals that all of the patients have the same disease, 
characterized by large, hypercellular glomeruli with 
neutrophil infiltration. Which patient has the best prognosis?   
 
1.  65-year-old nulliparous woman  
2.  50-year-old man with a history of strep infection  
3.  8-year-old boy who undergoes no treatment  
4.  38-year-old man with sickle cell trait  
5.  18-year-old man treated with corticosteroids  
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
The correct answer is 3   
Age is the most important prognostic factor in post-
streptococcal glomerulonephritis. Ninety-five percent of 
affected children recover completely, compared with 25% of 
adults over 60 years old.  
Incorrect answers: 
1, 2, & 4: Older adults are more likely to progress to end-stage 
renal disease. 
5: Corticosteroids may be used in refractory cases but are 
unlikely to result in a cure. 
 
 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
Epidemiology 1  
https://online.epocrates.com/diseases/20723/Glomerulonephritis/Epidemiology http://www.ncbi.nlm.nih.gov/pubmed/21068142 
• For every patient with clinically apparent GN, 
approximately 5 to 10 patients have undiagnosed 
subclinical disease. 
• Incidence rates of primary GN vary between 
0.2/100,000/year and 2.5/100,000/year.  
• Focal segmental glomerulosclerosis is the most 
common cause of GN, especially among black 
patients.  
• Membranous nephropathy (MN) used to be the 
most common biopsy diagnosis in adult patients.  
Epidemiology 2 
https://online.epocrates.com/diseases/20723/Glomerulonephritis/Epidemiology http://www.ncbi.nlm.nih.gov/pubmed/21068142 
• Idiopathic MN is more common in white men >40 
years of age.  
• MN is associated with lupus in young women and 
with hepatitis B in children. 
• The incidence of IgA nephropathy is at least 
2.5/100,000/year in adults; this disease can exist 
subclinically. 
Epidemiology   
( Acute Postinfectious Glomerulonephritis Worldwide) 
http://www.nature.com/nrneph/journal/v5/n5/images/nrneph.2009.44-f1.jpg 
Incidence is given as cases per year; prevalence is given as 
cases per 100,000 population. a Data from children. bData 
from adults. cData provided by Dr Tray Hunley, Division of 
Pediatric Nephrology, Vanderbilt Children's Hospital, 
Nashville, TN, USA. 
Epidemiology   
(Chronic GN and chronic kidney disease) 
http://www.annalsafrmed.org/article.asp?issn=1596-3519;year=2012;volume=11;issue=1;spage=21;epage=26;aulast=Chijioke 
Etiology of chronic kidney disease (CKD): HTN = 
Hypertension, CGN = Chronic Glomerulonephritis, DM 
= Diabetes Mellitus, PKD = Polycystic Kidney Disease, 
CPN = Chronic Pyelonephritis, OU = Obstructive 
Nephropathy 
Risk Factors 1 
• Disorders of the lymphatic system. 
• Blood disorders. 
• Family or personal history of cancer or malignant 
tumors. 
• Exposure to chemicals such as toxic hydrocarbon 
solvents. 
• Recurring strep infections or skin abscesses. 
• Viral infections.  
http://www.home-remedies-for-you.com/glomerulonephritis/causes.html 
Risk Factors 2 
• Heart infections. 
• Specific diseases (amyloidosis, vasculitis, 
polyarthritis, Goodpasture syndrome, IgA 
nephropathy, NSAIDs, lupus nephritis, Henoch-
Schonlein purpura, etc.). 
http://www.home-remedies-for-you.com/glomerulonephritis/causes.html 
Etiology 1  
https://online.epocrates.com/diseases/20721/Glomerulonephritis/Definition 
• Renal-limited glomerulopathy or glomerulopathy-
complicating systemic disease. 
• Inflammation due to leukocyte infiltration, antibody 
deposition, and complement activation.    
• Other causes:  
• Infections (e.g., group A beta-
hemolytic Streptococcus, other bacterial 
infections, viruses). 
• Systemic inflammatory (e.g., SLE, rheumatoid 
arthritis).  
Etiology 2  
https://online.epocrates.com/diseases/20721/Glomerulonephritis/Definition 
• Drugs (e.g., penicillamine, NSAIDs, captopril, 
heroin). 
• Metabolic disorders (diabetes mellitus, 
thyroiditis). 
• Malignancy (e.g., lung and colorectal cancer, 
Hodgkin lymphoma) 
• Hereditary (Fabry disease, Alport syndrome, etc.). 
• Deposition diseases (amyloidosis, light chain 
deposition disease). 
Etiology  
(The Spectrum of Glomerular Diseases) 
http://oxfordmedicine.com/doc/10.1093/med/9780199592548.001.0001/med-9780199592548-graphic-185-full.gif 
Etiology  
(Causes of Renal Disease and GN) 
http://image.slidesharecdn.com/cpc-4-4-1-ren-gn-pathlec-view-091013211218-phpapp02/95/pathology-of-glomerulonephritis-29-728.jpg?cb=1255468487 
USMLE TEST 
A 9-year-old Caucasian girl presents to your office with 
hematuria. An electron micrograph of her renal biopsy is 
shown below in Figure A. Which of the following is the most 
likely composition of the structures marked by the white 
arrows?   
1.  Albumin  
2.  Non-enzymatic glycosylation  
3.  IgA  
4.  IgG  
5.  IgG, IgM, C3  
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
The correct answer is 5 
The patient's presentation and EM are consistent with post-
streptococcal (postinfectious) glomerulonephritis. The white 
arrows demonstrate epimembranous immune complex 
deposits of IgG, IgM and C3.  Figure A shows the classic 
epimembranous immune complex deposition on EM 
Incorrect answers: 
1: Albumin is not the structure seen in this EM. 
2: Non-enzymatic glycosylation would not be visible on EM. 
3: While IgA nephropathy has granular EM deposits, they are 
located in the mesangium and not in the sub-epithelium. 
4: The deposits identified contain IgM and C3 in addition to IgG  
 https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
Mechanisms 
(Key Position of Immunologic Response) 1  
http://emedicine.medscape.com/article/239278-overview#a3 
• Most cases of GN are due to an immunologic 
response to a variety of different etiologic agents.  
• The immunologic response, in turn, activates a 
number of biological processes (e.g., complement 
activation, leukocyte recruitment, and release of 
growth factors and cytokines) that result in 
glomerular injury and inflammation.  
Mechanisms 
(Key Position of Immunologic Response) 2  
http://emedicine.medscape.com/article/239278-overview#a3 
• GN may be isolated to the kidney (primary 
glomerulonephritis) or be a component of a 
systemic disorder (secondary glomerulonephritis). 
•  Humoral (also referred to T helper cell 2-regulated) 
immune response to a variety of inciting agents 
results in immunoglobulin deposition and 
complement activation within the glomeruli.    
Mechanisms 
(Acute GN) 1 
http://emedicine.medscape.com/article/239278-overview#a3 
• Glomerular lesions are the result of glomerular 
deposition or in situ formation of immune 
complexes.  
• On gross appearance, the kidneys may be enlarged 
up to 50%.  
• Histopathologic changes include swelling of the 
glomerular tufts and infiltration with 
polymorphonucleocytes.   
Mechanisms 
(Acute GN) 2 
http://emedicine.medscape.com/article/239278-overview#a3 
• Immunofluorescence reveals deposition of 
immunoglobulins and complement. 
• Except in poststreptococcal glomerulonephritis 
(PSGN), the exact triggers for the formation of the 
immune complexes are unclear.  
• In PSGN, involvement of derivatives of streptococcal 
proteins has been reported.   
Mechanisms 
(Chronic GN: Reduction in Nephron Mass) 1  
http://emedicine.medscape.com/article/239392-overview#a4 
• Reduction in nephron mass from the initial injury 
reduces the glomerular filtration rate (GFR), that 
leads to hypertrophy and hyperfiltration of the 
remaining nephrons and to the initiation of 
intraglomerular hypertension with further 
glomerulosclerosis and nephron loss. 
• In early renal disease, a substantial decline in the 
GFR may lead to only slight increases in serum 
creatinine levels.   
Mechanisms 
(Chronic GN: Reduction in Nephron Mass) 2  
http://emedicine.medscape.com/article/239392-overview#a4 
• Azotemia (i.e., a rise in blood urea nitrogen (BUN) 
and serum creatinine levels) is apparent when the 
GFR decreases to less than 60-70 mL/min.   
Mechanisms 
(Chronic GN: Reduction in in the Glomerular 
Filtration Rate) 1 
http://emedicine.medscape.com/article/239392-overview#a4 
• Decreased production of erythropoietin, thus 
resulting in anemia. 
• Decreased production of vitamin D, resulting in 
hypocalcemia, secondary hyperparathyroidism, 
hyperphosphatemia, and renal osteodystrophy. 
• Reduction in acid, potassium, salt, and water 
excretion, resulting in acidosis, hyperkalemia, 
hypertension, and edema.  
Mechanisms 
(Chronic GN: Reduction in in the Glomerular 
Filtration Rate) 2 
http://emedicine.medscape.com/article/239392-overview#a4 
• Platelet dysfunction, leading to increased bleeding 
tendencies. 
• Accumulation of toxic waste products (uremic 
toxins) affects virtually all organ systems.  
• Uremia occurs at a GFR of approximately 10 
mL/min.   
Mechanisms 
(Possible Pathogenic Mechanism of 
Poststreptococcal GN)  
http://www.nature.com/nrneph/journal/v5/n5/fig_tab/nrneph.2009.44_F5.html 
Abbreviations: GADPH - streptococcal glyceraldehyde 
phosphate dehydrogenase, GBM - glomerular 
basement membrane, MMP -matrix 
metalloproteinase, SpeB - streptococcal cationic 
proteinase exotoxin B. 
Mechanisms 
(Focal Necrotizing GN)  
http://www.nature.com/nrneph/journal/v5/n5/fig_tab/nrneph.2009.51_F1.html 
The formation of crescents and the glomerular 
capillary necrosis (hematoxylin and eosin stain; 
original magnification 400). 
Mechanisms 
(Focal Necrotizing GN)  
http://www.nature.com/nri/journal/v13/n10/full/nri3523.html 
The time-dependent changes in the pro-inflammatory 
and anti-inflammatory functions of leukocyte subsets 
during the course of  crescentic GN. 
Mechanisms 
(Chronic Renal Failure can Result from a GN)  
http://intranet.tdmu.edu.ua/data/kafedra/internal/magistr/classes_stud/English/First%20year/Clinical%20Pathophysiology%20of%20Diseases/05.%20CP%20of%20kidney.htm 
All forms of renal failure are characterized by a 
reduction in the GFR, reﬂecting a corresponding 
reduction in the number of functional nephrons. 
USMLE TEST 
A 21-year-old male presents to your office with hematuria 3 
days after the onset of a productive cough and fever. 
Following renal biopsy, immunofluorescence shows granular 
IgA deposits in the glomerular mesangium. Which of the 
following do you suspect in this patient?   
1.  Lipoid nephrosis, 2.  Berger’s disease, 3.  Poststreptococcal 
glomerulonephritis, 4.  Systemic lupus erythematosus,   
5.  HIV infection 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST The correct answer is 2 
Hematuria and immunofluorescence findings of IgA deposits in the 
mesangium suggest Berger’s disease (IgA glomerulonephropathy). 
Berger’s disease can occur concurrently or within several days of an 
infection. 
Incorrect answers: 
1: Lipoid nephrosis, or minimal change syndrome, is the most common 
cause of nephrotic syndrome in young children. IgA is not present in 
glomeruli, 3: Post-streptococcal glomerulonephritis classically occurs in 
children weeks, not days, after an infection with group A hemolytic 
streptococci. Immunofluorescence shows C3 and IgG, but not IgA, 4: 
Systemic lupus erythematosus commonly causes a diffuse proliferative 
glomerulonephritis. IgA is not present in glomeruli, 5: HIV infection is 
associated with focal segmental glomerulosclerosis, a cause of nephrotic 
syndrome in adults with refractory hypertension. IgA is not present in 
glomeruli. 
 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
Classification 
(International Classification of Diseases (ICD)) 1 
http://apps.who.int/classifications/icd10/browse/2016/en#/N00.2 
XIV Diseases of the genitourinary system.    
N00-N08 Glomerular diseases.    
 N00 Acute nephritic syndrome . 
 N01 Rapidly progressive nephritic syndrome.    
 N02 Recurrent and persistent hematuria.    
 N03 Chronic nephritic syndrome.  
 N04 Nephrotic syndrome .   
Classification 
(International Classification of Diseases (ICD)) 2 
http://apps.who.int/classifications/icd10/browse/2016/en#/N00.2 
XIV Diseases of the genitourinary system.    
N00-N08 Glomerular diseases.    
 N05 Unspecified nephritic syndrome.  
 N06 Isolated proteinuria with specified 
morphological lesion.  
 N07 Hereditary nephropathy, not elsewhere 
classified.  
 N08 Glomerular disorders in diseases classified 
elsewhere. 
Classification 
(Primary and Secondary GN) 
https://online.epocrates.com/diseases/20721/Glomerulonephritis/Definition 
• Primary: the pathologic process is limited to the 
kidney and not part of a systemic disease 
manifestation 
• Secondary:  systemic lupus erythematosus (SLE), 
Henoch-Schonlein purpura, Wegener 
granulomatosis, microscopic polyangiitis, 
cryoglobulinemia, thrombotic microangiopathies, 
deposition diseases (amyloidosis, light chain 
deposition disease), malignancies (Hodgkin 
lymphoma, lung and colorectal cancer). 
Classification 
(Nephrotic/Nephritic) 1 
https://online.epocrates.com/diseases/20721/Glomerulonephritis/Definition 
Nephrotic syndrome 
(nephrotic-range 
proteinuria, 
hypoalbuminemia, 
hyperlipidemia, and 
edema): 
• deposition diseases, 
• minimal change 
disease, 
• focal and segmental 
glomerulosclerosis, 
• membranous 
nephropathy, 
• membranoproliferativ
e GN.  
Classification 
(Nephrotic/Nephritic) 2 
https://online.epocrates.com/diseases/20721/Glomerulonephritis/Definition 
Nephritic syndrome 
(hematuria, 
subnephrotic-range 
proteinuria, and 
hypertension (HTN)): 
• IgA nephropathy, 
• postinfectious GN, 
• rapidly progressive 
GN, 
• vasculitis, 
• anti–glomerular 
basement 
membrane (anti-
GBM) GN. 
Classification 
(Nephritic and rapidly progressive GN (RPGN)) 
https://online.epocrates.com/diseases/20721/Glomerulonephritis/Definition 
• Granular immune deposits (immune complex 
mediated GN). 
• Linear immune deposits (anti-GBM GN). 
• Pauci-immune GN. 
Classification 
(Severity) 
https://online.epocrates.com/diseases/20736/Glomerulonephritis/Diagnostic-Criteria 
• Mild: asymptomatic isolated hematuria or 
proteinuria <2 g. 
• Moderate to severe: symptomatic proteinuria, 
hematuria, and reduced GFR (nephrotic and 
nephritic syndromes, and rapidly progressive GN). 
Clinical Investigation 
(Symptoms)   
Symptoms depend on whether patient have the acute 
or chronic form, and the cause and may include: 
• pink or cola-colored urine from red blood cells in 
urine (hematuria), 
• foamy urine due to excess protein (proteinuria), 
• high blood pressure (HTN), 
• fluid retention (edema) with swelling evident in 
face, hands, feet and abdomen, 
• fatigue from anemia or kidney failure. 
http://www.mayoclinic.org/diseases-conditions/glomerulonephritis/basics/symptoms/con-20024691 
Clinical Investigation 
(Post-Streptococcal Glomerulonephritis)   
https://i.ytimg.com/vi/bjwTnwvuY6E/hqdefault.jpg 
Clinical Investigation 
(Edema In Acute Renal Failure)   
intranet.tdmu.edu.ua 
Clinical Investigation  
(Sings)  1 
• Asymptomatic proteinuria (150 mg - 3 g per day). 
• Microscopic hematuria: >2 red blood cells (RBCs) 
per high power field in spun urine.  
• Macroscopic hematuria: brown or smoky urine. 
• Nephrotic syndrome: proteinuria >3.5 g/day, 
hypoalbuminemia less than 3.5 g/dL, edema, 
hypercholesterolemia and lipiduria.   
http://www.apiindia.org/medicine_update_2013/chap128.pdf 
Clinical Investigation  
(Sings)  2 
• Nephritic syndrome: abrupt onset with oliguria, 
hematuria, proteinuria, azotemia, edema and 
hypertension. 
• Rapidly progressive glomerulonephritis (RPGN): 
proteinuria, hematuria and renal failure developing 
over days to a week. 
• Chronic GN: proteinuria, hypertension, renal failure 
and smooth contracted kidneys on ultrasonography 
(USG) examination. 
http://www.apiindia.org/medicine_update_2013/chap128.pdf 
Clinical Investigation  
(Modalities)   
• About half of the people with acute GN have no 
symptoms. If symptoms do occur, the first to appear 
are tissue swelling, low volume dark urine.  
• In RPGN weakness, fatigue, and fever are the most 
frequent early symptoms. These patients have 
edema and usually produce very little urine.  
• Because chronic GN usually causes only very mild or 
subtle symptoms, it goes undetected for a long time 
in most patients . The disease may progress to 
kidney failure. 
http://www.merckmanuals.com/home/kidney-and-urinary-tract-disorders/kidney-filtering-disorders/glomerulonephritis-nephritic-syndrome 
Clinical Investigation  
(Complications)   
• Acute kidney failure.  
• Chronic kidney disease (CKD).  
• High blood pressure.  
• Nephrotic syndrome.  
http://www.mayoclinic.org/diseases-conditions/glomerulonephritis/basics/complications/con-20024691 
USMLE TEST 
A 25-year-old male visits his primary care physician with 
complaints of hemoptysis and dysuria. Serum blood urea 
nitrogen and creatinine are elevated, blood pressure is 
160/100 mm Hg, and urinalysis shows hematuria and RBC 
casts. A 24-hour urine excretion yields 1 gm/day protein. A 
kidney biopsy is obtained, and immunofluorescence shows 
linear IgG staining in the glomeruli. Which of the following 
antibodies is likely pathogenic for this patient’s disease?   
1.  Anti-DNA antibody, 2.  Anti-neutrophil cytoplasmic 
antibody (C-ANCA), 3.  Anti-neutrophil perinuclear antibody 
(P-ANCA), 4.  Anti-glomerular basement membrane antibody 
(Anti-GBM), 5.  Anti-phospholipid antibody  
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
The correct answer is 4 
The patient’s clinical picture, laboratory data, urinalysis, and light 
microscopy are consistent with Goodpasture syndrome. Goodpasture 
syndrome is a type II hypersensitivity reaction characterized by 
autoantibodies to the glomerular basement membrane (anti-GBM). 
Incorrect answers: 
1: Anti-DNA antibody is associated with the diffuse proliferative GN of 
SLE. 
2: Anti-neutrophil cytoplasmic antibody (C-ANCA) is associated with 
Wegener granulomatosis. 
3: Anti-neutrophil perinuclear antibody (P-ANCA) is associated with 
microscopic polyarteritis. 
5: Anti-phospholipid antibody is associated with an autoimmune, 
hypercoagulable state. 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
Diagnosis  
• Clinical data,  
• Urine examination. 
• Blood tests: complete blood cell count 
(CBC), inflammatory markers and special tests (anti-
streptolysin O  (ASLO), anti-neutrophil cytoplasmic 
antibodies  (ANCA), Anti-GBM antibody 
complement levels, antinuclear antibodies, 
• Imaging. 
• Biopsy of the kidney. 
 
https://en.wikipedia.org/wiki/Glomerulonephritis#Signs_and_symptoms 
Diagnosis 
(Clinical Data) 1 
• Clinical features vary depending on the etiology and 
may include one or a combination of the following: 
hematuria (macroscopic or more commonly 
microscopic), proteinuria, and edema (characteristic 
of nephrotic syndrome). 
• Hypertension may or may not be present, it is 
uncommon.  
https://online.epocrates.com/diseases/20731/Glomerulonephritis/Diagnostic-Approach 
Diagnosis 
(Clinical Data) 2 
• Patients may have features of the underlying 
disorder, for example: 
• joint pain, rash, and hemoptysis in vasculitis, 
• fever and sore throat in streptococcal infections, 
• jaundice in hepatitis B and C, 
• weight loss in malignancies, 
• stigmata of IV drug use. 
https://online.epocrates.com/diseases/20731/Glomerulonephritis/Diagnostic-Approach 
Diagnosis 
(Laboratory tests: 1)  
• A urinalysis and urine microscopy is generally the 
first test, and further testing is prompted on the 
basis of the results.  
• Other initial recommended tests include GFR and 
creatinine evaluation, 24-hour urine collection, CBC, 
metabolic profile, and lipid profile. 
• Urinalysis and renal function tests show hematuria 
and proteinuria. In complicated disease GFR and 
creatinine may suggest reduced renal function.  
https://online.epocrates.com/diseases/20731/Glomerulonephritis/Diagnostic-Approach 
Diagnosis 
(Laboratory tests: 2)  
• Proteinuria, measured by 24-hour urine collection, 
is generally <3.5 g/day, but if it is >3.5 g/day, 
patients are classified as having nephrotic-range 
proteinuria and may have full nephrotic syndrome 
(hyperlipidemia, hypoalbuminemia, edema, 
nephrotic-range proteinuria). 
• Hematuria is characterized by dysmorphic RBCs and 
formation of RBC casts that are best seen in freshly 
prepared urine sediments.  
https://online.epocrates.com/diseases/20731/Glomerulonephritis/Diagnostic-Approach 
Diagnosis 
(Laboratory tests: 3)  
• Anemia, hyperglycemia (if diabetic), hyperlipidemia 
(nephrotic picture), and hypoalbuminemia 
(nephrotic picture) may also be evident from the 
CBC, and from metabolic and lipid profiles. 
• If urinalysis indicates GN, subsequent tests are 
ordered to determine the etiology and hence to 
guide the treatment.  
https://online.epocrates.com/diseases/20731/Glomerulonephritis/Diagnostic-Approach 
Diagnosis 
(Laboratory tests: 4)  
• Specific serologic testing for systemic causes 
include erythrocyte sedimentation rate (ESR), 
complement, ANCAs, anti-GBM antibodies, 
monoclonal protein on serum or urine 
electrophoresis, antistreptococcal antibodies, 
circulating cryoglobulin, HIV serology, hepatitis B 
virus serology, hepatitis C virus serology, and drug 
toxicology screen. 
https://online.epocrates.com/diseases/20731/Glomerulonephritis/Diagnostic-Approach 
Diagnosis 
(Ultrasound)  
Morphological aspect of the kidney with acute kidney 
injury at B-mode renal ultrasound. 
http://www.esciencecentral.org/ebooks/ultrasound-approach/renal-ultrasound-in-acute-kidney-disease.php 
Diagnosis 
(Biopsy of the Kidney)  
Rapidly progressive ("crescentic") GN. Formation of crescents 
is initiated by passage of fibrin into the Bowman space. Fibrin 
stimulates the proliferation of parietal cells of Bowman 
capsule, and an influx of monocytes. Rapid growing and 
fibrosis of crescents compresses the capillary loops and 
decreases the Bowman space which leads to renal failure. 
(H&E, ob. x20). 
http://www.pathologyatlas.ro/rapidly-progressive-crescentic-glomerulonephritis.php 
Diagnosis 
(Distinguishing Acute Kidney Injury From 
Chronic Kidney Disease)  
https://www.merckmanuals.com/professional/genitourinary-disorders/chronic-kidney-disease/chronic-kidney-disease 
Diagnosis 
(Renal Biopsy Definitive Diagnosis of GN)  
https://online.epocrates.com/diseases/20731/Glomerulonephritis/Diagnostic-Approach 
Diagnosis 
(Staging CKD)  
1. Normal GFR (≥ 90 mL/min/1.73 m2) plus either persistent 
albuminuria or known structural or hereditary renal 
disease. 
2. GFR 60 to 89 mL/min/1.73 m2 . 
3. GFR 30 to 59 mL/min/1.73 m2 . 
4. GFR 15 to 29 mL/min/1.73 m2  . 
5. GFR < 15 mL/min/1.73 m2 . 
GFR (in mL/min/1.73 m2) in CKD can be estimated by: 186.3 × (serum 
creatinine)−1.154×(age)− 0.203. The result is multiplied by 0.742 if the 
patient is female and by 1.21 if the patient is African American. For 
female African Americans, the result is multiplied by 0.742 × 1.21 
(0.898).   
https://online.epocrates.com/diseases/20731/Glomerulonephritis/Diagnostic-Approach 
Diagnosis 
(Differential)  
https://online.epocrates.com/diseases/20735/Glomerulonephritis/Differential-Diagnosis 
Condition Differentiating Signs/Symptoms Differentiating Tests 
Nephrolithiasis Severe pain in addition to hematuria 
depend on the position of the stone. 
Hematuria, no dysmorphic RBC. Renal 
ultrasound reveals the stone. 
Bladder cancer Painless hematuria. Patients are older 
and with a history of smoking. 
Hematuria, no dysmorphic RBCs. 
Diagnosis is made by cystoscopic biopsy. 
Renal cancer A triad of flank pain, fever, and 
hematuria is typical.   
Hematuria, no dysmorphic RBCs. Imaging 
by CT would reveal a renal mass. 
Pre- or post-
renal failure 
Vague generalized symptoms (fatigue, 
loss of appetite, and nausea) besides 
those of the underlying etiology. 
No dysmorphic RBCs or casts. Fractional 
excretion of sodium is <1% in azotemia 
due to prerenal causes. Renal imaging 
shows obstructive uropathy. 
USMLE TEST 
A 37-year-old man presents with significant hematuria and 
hemoptysis. The results of the immunoflouresence are shown 
in Figure A. What pathologic changes would be expected 
under light microscopy?  
1.  "Wire looping" of the capillaries  
2.  Hypercellular glomeruli  
3.  Crescentic glomerulonephritis  
4.  Focal proliferative glomerulonephritis  
5.  Normal glomeruli  
 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
The correct answer is 3 
The clinical scenario and attached image are consistent with 
Goodpasture syndrome, a type of rapidly progressive crescentic 
glomerulonephritis (RPGN). 
Incorrect answers: 
1: "Wire looping" of the capillaries on light microscopy (LM) is typical of 
diffuse proliferative glomerulonephritis and is associated with SLE. 
2: Hypercellular glomeruli on LM are typical of post-streptococcal 
glomerulonephritis. 
4: Focal proliferative changes on LM are characteristic of IgA 
nephropathy or Berger disease, which can be associated with Henoch-
Schoenlein Purpura if extra-renal symptoms are present. 
5: Normal glomeruli on LM could be seen in minimal change disease 
which is a nephrotic, not nephritic disorder. 
 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
Treatment 
(Lifestyle and Dietary Advice) 
• People with chronic GN be encouraged to 
undertake physical activity compatible with 
cardiovascular health and tolerance (aiming for at 
least 30 min five times per week), achieve a healthy 
weight (body mass index 20–25 kg/m2, according to 
country-specific demographics), and stop smoking. 
• People with chronic GN receive expert dietary 
advice and information in the context of an 
education program, tailored to severity of CKD and 
the need to intervene on salt, phosphate, 
potassium, and protein intake where indicated.  
http://www.medscape.com/viewarticle/819798_10 
Treatment 
(Goal of Specific Therapy) 
• The goal of specific therapy for GN is to reverse the 
renal damage or to preserve the renal function, that 
is monitored by checking renal function and the 
degree of proteinuria.  
• Most of the specific treatment include 
plasmapheresis, corticosteroid therapy, and 
immunosuppression. 
• Complications such as HTN and hyperlipidemia 
should be managed appropriately to counteract 
cardiovascular events, as well as to delay 
progression of renal pathology. 
• Treatment is patient specific and directed toward 
the underlying etiology and managing the 
complications. 
https://online.epocrates.com/diseases/20741/Glomerulonephritis/Treatment-Approach 
Treatment 
(Mild Disease) 
Patients who present with isolated hematuria, 
minimal or no proteinuria, and a normal GFR have a 
better outcome and may not need specific therapies 
other than treating the systemic cause (e.g., 
antibiotics, antivirals, withdrawal of the causative 
drug). 
https://online.epocrates.com/diseases/20741/Glomerulonephritis/Treatment-Approach 
Treatment 
(Moderate to Severe Disease) 1 
• Patients with hematuria, proteinuria, and reduced 
GFR are managed with specific therapies targeted 
at reversing the underlying etiology, for example, 
antibiotics in acute nephritic poststreptococcal GN. 
• Nonspecific pharmacologic measures that reduce 
proteinuria and are also first-line considerations for 
controlling HTN, including  angiotensin-converting 
enzyme (ACE) or angiotensin-II receptor 
antagonists.  
http://www.apiindia.org/medicine_update_2013/chap128.pdf 
Treatment 
(Moderate to Severe Disease) 2 
• Edema is controlled by salt-restricted diet (1–2 
g/day), oral or intravenous (IV) loop diuretics alone 
or combined with thiazide. 
• Severe disease presenting as nephrotic syndrome is 
usually treated with corticosteroids and 
immunosuppressants.    
http://www.apiindia.org/medicine_update_2013/chap128.pdf 
Treatment 
(Anticoagulation and Statins) 
• Anticoagulation with low molecular weight heparin 
or warfarin is mandatory if serum albumin is below 
2 g/dL with one or more of the following: 
proteinuria greater than 10 g/day, body mass index 
greater than 35 kg/m2, family history of 
thromboembolism, congestive heart failure, recent 
abdominal or orthopedic surgery or prolonged 
immobilization. 
• Statins are well tolerated and effective in correcting 
lipid profile, but not proven to reduce 
cardiovascular events.  
http://www.apiindia.org/medicine_update_2013/chap128.pdf 
Treatment 
(Rapidly Progressive Disease (RPGN)) 
• Categorized into the following: 
• Antiglomerular basement membrane (linear type), 
• Immune-complex mediated (granular type): 
postinfectious causes, connective tissue disease, IgA 
nephropathy, and membranoproliferative GN, 
• Pauci-immune: Wegener granulomatosis and 
polyarteritis nodosa. 
• Corticosteroids and immunosuppressant therapy 
with or without plasmapheresis are the mainstay of 
treatment for severe and progressive disease. 
https://online.epocrates.com/diseases/20741/Glomerulonephritis/Treatment-Approach 
Treatment 
(Definitive Diagnosis and Treatment of GN)  
https://online.epocrates.com/diseases/20731/Glomerulonephritis/Diagnostic-Approach 
Treatment 
(End-stage Renal Disease Therapy) 
• Hemodialysis. 
• Peritoneal 
dialysis. 
• Renal 
transplantation. 
http://www.mayoclinic.org/tests-procedures/peritoneal-dialysis/home/ovc-20202856 http://emedicine.medscape.com/article/239392-overview#showall 
USMLE TEST 
A 62-year-old man presents to his primary care doctor complaining of 
recent-onset hemoptysis. He has not had any fevers, night sweats, or 
weight loss. He recently traveled to Italy with his wife. He has a 5 pack-
year smoking history. On review of systems, he reports that his urine has 
been “red-tinged” for several months. Urinalysis reveals the findings 
shown in Figure A. He is referred to a nephrologist and undergoes a 
renal biopsy. Immunofluorescence staining of the biopsy is shown in 
Figure B. Which of the following is the most likely underlying 
pathogenesis of his disease?   
1.  Type III hypersensitivity reaction, 2.  Antibodies to collagen type IV, 
3.  Presence of C-ANCA, 4.  Mycobacterial infection, 5.  Metastatic 
malignancy  
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
USMLE TEST 
The correct answer is 2 
This patient has pulmonary hemorrhage and nephritic syndrome. His 
renal biopsy shows linear deposition of antibodies along the basement 
membrane in the glomerulus, a finding characteristic of Goodpasture 
disease. 
Incorrect answers: 
1: Goodpasture disease is a type II hypersensitivity reaction, 3: C-ANCA 
disorders include granulomatosis with polyangiitis (Wegner's), which can 
cause pulmonary and renal symptoms. However, this diagnosis would 
not show a linear fluorescent staining pattern, 4: Tuberculosis is a 
mycobacterial infection that can affect many organ systems. However, 
this man does not have significant risk factors for tuberculosis, and his 
biopsy is diagnostic of Goodpasture disease, 5: He has not had weight 
loss or other systemic signs suggestive of metastatic malignancy. 
Moreover, his biopsy results are diagnostic of an autoimmune process. 
https://wire.ama-assn.org/education/usmle-step-2-prep-next-best-step-hypertension-and-shortness-breath 
Treatment 
(Lifestyle and Dietary Advice) 
• People with chronic GN be encouraged to 
undertake physical activity compatible with 
cardiovascular health and tolerance (aiming for at 
least 30 min five times per week), achieve a healthy 
weight (body mass index 20–25 kg/m2, according to 
country-specific demographics), and stop smoking. 
• People with chronic GN receive expert dietary 
advice and information in the context of an 
education program, tailored to severity of CKD and 
the need to intervene on salt, phosphate, 
potassium, and protein intake where indicated.  
http://www.medscape.com/viewarticle/819798_10 
Prognosis 1  
• Most epidemic cases follow a course ending in 
complete patient recovery (as many as 100%). The 
mortality of acute GN has been reported at 0-7%. 
• Sporadic cases of acute GN often progress to a 
chronic GN. This progression occurs in as many as 
30% of adult patients and 10% of pediatric patients. 
GN is the most common cause of CKD (25%).  
• Approximately 15% of patients at 3 years and 2% of 
patients at 7-10 years may have persistent mild 
proteinuria.   
 http://emedicine.medscape.com/article/239278-overview#showall 
Prognosis 2  
 
• Generally, the prognosis is worse in patients with 
heavy proteinuria, severe hypertension, and 
significant elevations of creatinine level.  
• Serum creatinine levels and the proportion of 
crescents were the most important predictors of 
developing CKD. 
 
http://emedicine.medscape.com/article/239278-overview#showall 
Prophylaxis 
• There may be no way to prevent most forms of GN.  
• Some interventions may be beneficial: 
• prompt treatment of a strep infection, 
• prompt treatment of a  viral infection, 
• control high blood pressure 
• control blood sugar. 
http://www.mayoclinic.org/diseases-conditions/glomerulonephritis/basics/prevention/con-20024691 
Abbreviations  
HTN - hypertension  
MMP - matrix metalloproteinase 
NSAIDs - nonsteroidal anti-inflammatory 
drugs  
PKD - polycystic kidney disease 
PSGN - poststreptococcal 
glomerulonephritis 
RBCs - red blood cells  
RPGN - rapidly progressive GN 
SLE  - systemic lupus erythematosus 
anti-GBM antibody - anti–glomerular 
basement membrane antibody 
SpeB - streptococcal cationic proteinase 
exotoxin B 
USG - ultrasonography  
phosphate dehydrogenase 
OU - obstructive nephropathy 
ACE - angiotensin-converting enzyme  
ANCAs - anti-neutrophil cytoplasmic 
antibodies   
ASLO - anti-streptolysin O   
BUN - blood urea nitrogen  
CBC - complete blood cell count 
CGN - chronic glomerulonephritis 
CKD - chronic kidney disease 
DM - diabetes mellitus 
ESR - erythrocyte sedimentation rate 
ESRD -  end-stage renal disease  
GADPH - streptococcal glyceraldehyde  
GBM - glomerular basement membrane 
GFR - glomerular filtration rate  
GI – gastrointestinal 
GN – glomerulonephritis 
HIV - the human immunodeficiency virus 
 
Diagnostic and treatment guidelines 
KDIGO Clinical Practice Guideline for Glomerulonephritis 
Acute Glomerulonephritis: Evidence-based Management 
Evidence-based clinical practice guidelines for rapidly progressive 
glomerulonephritis 2014 
Acute kidney injury: prevention, detection and management 
 
